Neuronetics

Contributing Author

Recent Articles by Neuronetics

Sep-17	New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) STIM GlobeNewswire
Aug-06	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM GlobeNewswire
Aug-05	Neuronetics Reports Second Quarter 2025 Financial and Operating Results STIM GlobeNewswire
Aug-04	Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference STIM GlobeNewswire
Jul-30	NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents STIM GlobeNewswire
Jul-22	Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call STIM GlobeNewswire
Jul-15	Neuronetics Appoints New Chief Financial Officer STIM GlobeNewswire
Jun-19	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM GlobeNewswire
Jun-10	Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program STIM GlobeNewswire
Jun-02	Neuronetics Set to Join Russell 2000 and Russell 3000 Indexes STIM GlobeNewswire
May-14	Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month STIM GlobeNewswire
May-06	Neuronetics Reports First Quarter 2025 Financial and Operating Results STIM GlobeNewswire
May-05	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM GlobeNewswire